Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1989-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9378(89)90870-3PMID 2525337
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

  1988cited by this paper
• Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.

  1988cited by this paper
• The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.

  1988cited by this paper
• A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.

  1988cited by this paper
• Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol.

  1988cited by this paper
• Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis.

  1988cited by this paper
• Pelvic Endometriosis: Etiology and Pathology

  1988cited by this paper
• LHRH analogues and bone loss.

  1987cited by this paper
• Treatment of Endometriosis With a Long‐Acting Gonadotropin‐Releasing Hormone Agonist

  1987cited by this paper
• Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

  1987cited by this paper
• Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

  1986cited by this paper
• Revised American Fertility Society classification of endometriosis: 1985.

  1985cited by this paper
• Revised American Fertility Society classification of endometriosis: 1985

  1985cited by this paper
• Lowering blood cholesterol to prevent heart disease. NIH Consensus Development Conference Statement.

  1985cited by this paper
• Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin).

  1985cited by this paper
• Lowering Blood Cholesterol to Prevent Heart Disease

  1985cited by this paper
• Consensus Development Conference

  1984cited by this paper
• Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women.

  1984cited by this paper
• Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis.

  1983cited by this paper
• "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.

  1982cited by this paper
• High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

  1977cited by this paper
• American Fertility Society

  1970cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• An improved method for simultaneous determination of exchangeable body sodium and potassium.

  1955cited by this paper

• A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action

  2024cites this paper
• Gonadotropin-releasing hormone analogues for endometriosis.

  2023cites this paper
• Molecular Imaging of Endometriosis Tissues using Desorption Electrospray Ionization Mass Spectrometry

  2019cites this paper
• “Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review

  2017cites this paper
• “ PER VAGINAM ” 1 TOPYCAL USE OF HORMONAL DRUGS IN WOMEN WITH SYMPTOMATIC DEEP 2 ENDOMETRIOSIS : A NARRATIVE LITERATURE REVIEW 3

  2017cites this paper
• 27 Medical Treatment in Endometriosis

  2012cites this paper
• Medical Treatment in Endometriosis

  2012cites this paper
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.

  2010cites this paper
• Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.

  2008cites this paper
• WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.

  2007cites this paper
• Ovulation suppression for endometriosis.

  2007cites this paper
• Ovulation suppression for endometriosis for women with subfertility

  2007cites this paper
• Danazol for unexplained subfertility.

  2007cites this paper
• A Randomized, Parallel, Comparative Study of the Efficacy and Safety of Nafarelin Versus Danazol in the Treatment of Endometriosis in Taiwan

  2005cites this paper
• Successful conservative treatment of catamenial pneumothorax with GnRH agonist

  2004cites this paper
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.

  2000cites this paper
• WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.

  1999cites this paper
• The evidence for the management of endometriosis.

  1998cites this paper
• GnRH agonists and add‐back therapy: is there a perfect combination?

  1998cites this paper
• The Role of GnRH Agonists Plus Add-Back Therapy in the Treatment of Endometriosis

  1997cites this paper
• Medical treatment of symptomatic endometriosis.

  1996cites this paper
• The impact ofd-Trp6 LH-RH on plasma lipid levels

  1996cites this paper
• The impact of GnRH agonist and menotropin therapy on lipoprotein metabolism.

  1996cites this paper
• Gonadotropin releasing hormone agonists and hormone replacement theory

  1996cites this paper
• Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal "add-back" paradigms.

  1995cites this paper
• Infertility treatment: From cookery to science. The epidemiology of randomized controlled trials

  1994cites this paper
• Long-term gonadotrophin-releasing hormone agonist therapy: the evolving issue of steroidal 'add-back' paradigms.

  1994cites this paper
• Infertility treatment: from cookery to science. The epidemiology of randomised controlled trials

  1993cites this paper
• Safety of GnRH Agonists: Short-Term Side Effects and Cyst Formation

  1993cites this paper
• Changing concepts of medical treatment of endometriosis

  1993cites this paper
• Management of endometriosis in women older than 40 years of age.

  1993cites this paper
• Endometriosis: medical therapy.

  1993cites this paper
• Pathophysiology and management of endometriosis.

  1993cites this paper
• The Use of GnRH Agonists in the Medical Therapy of Endometriosis in the Woman with Pain

  1993cites this paper
• 9 Endometriosis: Medical therapy

  1993cites this paper
• Nafarelin for endometriosis: A large‐scale, danazol‐controlled trial of efficacy and safety, with 1‐year follow‐up

  1992cites this paper
• The role of GnRH analogues in the treatment of endometriosis

  1992cites this paper
• Die GnRH-Analoga-Therapie (Enantone®-Gyn Monats-Depot und ihr Einfluß auf den Lipidstoffwechsel

  1992cites this paper
• Secondary Dyslipidemia: Inadvertent Effects of Drugs in Clinical Practice

  1992cites this paper
• The use of danazol as a treatment of endometriosis

  1991cites this paper
• Heterosteroids and drug research.

  1991cites this paper
• Pulmonary endometriosis: conservative treatment with GnRH agonists.

  1991cites this paper
• Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol

  1991cites this paper
• Nafarelin Acetate: A Gonadotropin-Releasing Hormone Agonist for the Treatment of Endometriosis

  1990cites this paper
• Comparison of the pharmacology of nafarelin and danazol.

  1990cites this paper
• Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions.

  1990cites this paper
• Hysterectomy. A critical review.

  1990cites this paper
• Efficacy and safety of nafarelin in the treatment of endometriosis.

  1990cites this paper